IRIS
PISANI, ANTONIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.932
EU - Europa 1.780
AS - Asia 646
AF - Africa 64
SA - Sud America 7
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 2
Totale 5.435
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.873
IT - Italia 979
CN - Cina 434
FI - Finlandia 150
VN - Vietnam 142
UA - Ucraina 121
IE - Irlanda 113
DE - Germania 101
NL - Olanda 78
CI - Costa d'Avorio 60
CA - Canada 57
SE - Svezia 46
RO - Romania 45
FR - Francia 43
GB - Regno Unito 34
IN - India 24
MK - Macedonia 22
IR - Iran 12
BE - Belgio 11
TR - Turchia 10
BG - Bulgaria 9
SG - Singapore 8
HK - Hong Kong 7
RU - Federazione Russa 7
PL - Polonia 6
CH - Svizzera 5
EU - Europa 4
JP - Giappone 4
SI - Slovenia 4
EG - Egitto 3
VE - Venezuela 3
AU - Australia 2
BR - Brasile 2
ES - Italia 2
GR - Grecia 2
IL - Israele 2
MX - Messico 2
MY - Malesia 2
CO - Colombia 1
HR - Croazia 1
IM - Isola di Man 1
PE - Perù 1
PK - Pakistan 1
ZA - Sudafrica 1
Totale 5.435
Salva come PNG Salva come JPEG
Città #
Chandler 553
Napoli 241
Millbury 219
Ashburn 158
Princeton 158
Nanjing 145
Dong Ket 142
Beijing 119
Jacksonville 119
Boston 113
Des Moines 98
Wilmington 95
Amsterdam 74
Naples 71
Lawrence 56
Ottawa 53
Rome 47
Bucharest 45
Nanchang 39
Dublin 36
Caserta 33
Milan 33
Hebei 28
Shenyang 28
Redwood City 20
Woodbridge 20
Boardman 19
Norwalk 18
Washington 18
Jiaxing 17
Seattle 17
Augusta 15
Tianjin 15
Houston 14
Ann Arbor 11
Courcelles 11
Kunming 11
Los Angeles 11
Frankfurt am Main 10
Sciacca 10
Duncan 9
Skopje 9
Sofia 9
Changsha 8
Fairfield 8
Falls Church 8
San Mateo 8
Mugnano di Napoli 7
New York 7
Salerno 7
Hong Kong 6
Kronberg 6
Pune 6
San Giorgio Del Sannio 6
Baar 5
Leawood 5
Orange 5
Riccione 5
Saponara 5
Sesto San Giovanni 5
Antalya 4
Bari 4
Casoria 4
Council Bluffs 4
Hangzhou 4
Lowicz 4
Marano Di Napoli 4
Mountain View 4
Ningbo 4
Redmond 4
San Giorgio La Molara 4
Torino 4
Turin 4
Abano Terme 3
Altamura 3
Bergamo 3
Brescia 3
Formia 3
Genova 3
Indiana 3
Istanbul 3
Jinan 3
Kish 3
Lappeenranta 3
Maddaloni 3
Marigliano 3
Menlo Park 3
Molise 3
Nardò 3
Padova 3
Pomezia 3
Pozzuoli 3
San Antonio 3
San Giovanni Rotondo 3
Scuola 3
Tappahannock 3
Trento 3
Vicenza 3
Absecon 2
Aci Sant'Antonio 2
Totale 3.205
Salva come PNG Salva come JPEG
Nome #
Polimirfismo del gene dell'ACE ed eritrocitosi nel trapianto di rene 268
Liposomial iron: a new proposal for the treatment of anaemia in chronic kidney disease 97
Bowel obstruction and peritoneal carcinomatosis in the elderly. A systematic review 85
Il nefrologo nel trattamento dell’iperammoniemia da disordini del ciclo dell’urea 75
Parapelvic cysts, a distinguishing feature of renal Fabry Disease. 65
Effect of a Short-Course Treatment with Synbiotics on Plasma p-Cresol Concentration in Kidney Transplant Recipients. 65
Diagnostic, Predictive, Prognostic, and Therapeutic Molecular Biomarkers in Third Millennium: A Breakthrough in Gastric Cancer 65
Antiproteinuric effect of add-on paricalcitol in Fabry disease patients: a prospective observational study. 61
Immunosuppression and multiple primary malignancies in kidney transplanted patients. A single-institute study 59
Aortopathies in mouse models of Pompe, Fabry and Mucopolysaccharidosis IIIB lysosomal storage diseases 57
Agalsidase alfa and agalsidase beta in the treatment of Fabry disease: does the dose really matter? 56
6-tips diet: a simplified dietary approach in patients with chronic renal disease. A clinical randomized trial 55
A novel GLA mutation in a Fabry family with glucose-6-phosphate dehydrogenase deficiency 53
Hybrid positron emission tomography-magnetic resonance imaging for assessing different stages of cardiac impairment in patients with Anderson-Fabry disease: AFFINITY study group 52
Alterations of functional connectivity of the motor cortex in Fabry disease: An RS-fMRI study 52
Molecular Mechanisms of Renal Cellular Nephrotoxicity due to Radiocontrast Media 50
Effect of paricalcitol vs calcitriol on hemoglobin levels in chronic kidney disease patients: a randomized trial 48
Long-term Effects of Octreotide on Liver Volume in Patients With Polycystic Kidney and Liver Disease 48
Corpus callosum involvement: a useful clue for differentiating Fabry Disease from Multiple Sclerosis 47
Current tissue molecular markers in colorectal cancer: A literature review 47
Default mode network modifications in Fabry disease: A resting-state fMRI study with structural correlations 46
A strange epigastric pain. 45
EC-MPS permits lower gastrointestinal symptom burden despite higher MPA exposure in patients with severe MMF-related gastrointestinal side-effects. 45
Endocrine dysfunction in patients with Fabry disease 44
Cardiac performance during exercise in patients with Fabry's disease 44
Early Cardiac Involvement Affects Left Ventricular Longitudinal Function in Females Carrying α-Galactosidase A Mutation: Role of Hybrid Positron Emission Tomography and Magnetic Resonance Imaging and Speckle-Tracking Echocardiography 44
Absence of infratentorial lesions in Fabry disease contributes to differential diagnosis with multiple sclerosis 44
Effects of atorvastatin on renal function in patients with chronic renal failure. PMID: 43
Inibizione del'angiotensina II e proteinuria in pazienti con glomerulonefrite IgA mesangiale 43
Enzyme replacement therapy in Fabry disease patients undergoing dialysis: effects on quality of life and organ involvement. Am J Kidney Dis. 2005 Jul;46(1):120-7. 42
Synergy between the pharmacological chaperone 1-deoxygalactonojirimycin and agalsidase alpha in cultured fibroblasts from patients with Fabry disease 42
Atorvastatin improves the course of ischemic acute renal failure in aging rats 42
Cerebrovascular and Brain Abnormalities In Autosomal-Dominant Polycystic Kidney Disease: Role Of 3d Time-of-Flight Magnetic Resonance Angiography 41
Pituitary function and morphology in Fabry disease. 41
Plasma p-cresol lowering effect of sevelamer in non-dialysis CKD patients: evidence from a randomized controlled trial 40
Progression of chronic renal failure in remnant rats: role of arginase inhibition 39
Terapia enzimatica sostitutiva nella malattia di Fabry: cosa abbiamo imparato dallo switch? 38
Prevention of contrast-induced nephropathy through a knowledge of its pathogenesis and risk factors 37
ACE-Inhibitor (ACE-i) and Eryhrocytosis in Renal Transplantation 37
Striatonigral involvement in Fabry Disease: A quantitative and volumetric Magnetic Resonance Imaging study 37
Arginase inhibition slows the progression of renal failure in rats with renal ablation 36
A clinical case of a giant lymphocele (LC) in a patient with a recent renal transplant is described 36
Redefining the Pulvinar Sign in Fabry Disease 36
Thyroid function in Fabry disease before and after enzyme replacement therapy. 35
Genetic variants associated with gastrointestinal symptoms in Fabry disease. 35
Treatment with Agalsidase Alfa during Pregnancy in a Heterozygous Female with Fabry Disease 35
Cardiac sympathetic neuronal damage precedes myocardial fibrosis in patients with Anderson-Fabry disease 35
Mutations in the GLA gene and LysoGb3: Is it really Anderson-Fabry disease? 35
The Choice of the Iodinated Radiographic Contrast Media to Prevent Contrast-Induced Nephropathy 34
Identifying Fabry patients in dialysis population: prevalence of GLA mutations by renal clinic screening, 1995–2019 34
ADPKD and metformin: from bench to bedside 34
Cisti epatica gigante in una paziente affetta da malattia policistica autosomica dominante 33
Effects of Ha-Ras inhibition on ischemic acute renal failure in the rat 33
Renal sympathetic-nerve ablation for uncontrolled hypertension in a patient with single-kidney autosomal dominant polycystic kidney disease. 33
Motor involvement in Fabry disease 33
Nutritional management in renal transplant recipients: A transplant team opportunity to improve graft survival 33
Optical Coherence Tomography Angiography Findings in Fabry Disease 33
C5 Convertase Blockade in Membranoproliferative Glomerulonephritis: A Single-Arm Clinical Trial 33
Antiproteinuric effect of angiotensin II blockade in patients with IgA nephropathy. 32
Effects of atorvastatin on renal function in patients with chronic renal failure. 32
Inibizione del'angiotensina II e proteinuria in pazienti con glomerulonefrite IgA mesangiale. 32
Effects of switching from agalsidase Beta to agalsidase alfa in 10 patients with anderson-fabry disease. 32
Endothelial-mediated coronary flow reserve in patients with Anderson-Fabry disease 32
Differential activation of signaling pathways by low-osmolar and Iso-osmolar radiocontrast agents in human renal tubular cells 32
Effect of oral liposomal iron versus intravenous iron for treatment of iron deficiency anaemia in CKD patients: A randomized trial 32
Prominent longitudinal strain reduction of left ventricular basal segments in treatment-naïve Anderson-Fabry disease patients 32
Anderson-Fabry's disease: diagnostic problems, therapeutic relevance, and clinical experience in the treatment of the disease with enzyme replacement therapy in nephropathic patients] 31
Reversal of radiocontrast medium toxicity in human renal proximal tubular cells by white grape juice extract 31
Home infusion program with enzyme replacement therapy for Fabry disease: The experience of a large Italian collaborative group 31
Clinical treatment of polycystic kidney disease (APKD): do we need further suggestions from rodents? 30
Relationship between left ventricular diastolic function and myocardial sympathetic denervation measured by (123)I-meta-iodobenzylguanidine imaging in Anderson-Fabry disease 30
Enzyme replacement therapy in patients with Fabry disease: state of the art and review of the literature 30
Agalsidase therapy in patients with Fabry disease on renal replacement therapy: a nationwide study in Italy. Nephrol Dial Transplant 29
Additive antiproteinuric effect of converting enzyme inhibitor and losartan in normotensive patients with IgA nephropathy. 29
Agalsidase therapy in patients with Fabry disease on renal replacement therapy: a nationwide study in Italy. 29
Anderson-Fabry's disease: diagnostic problems, therapeutic relevance, and clinical experience in the treatment of the disease with enzyme replacement therapy in nephropathic patients 29
Arterial aneurysms: autosomal dominant polycystic kidney disease, Marfan syndrome or both? 29
Atrial septum aneurysm: an unusual manifestation in ADPKD? 29
Liposomial iron: a new proposal for the treatment of anaemia in chronic kidney disease 29
What indication, morbidity and mortality for central pancreatectomy in oncological surgery? A systematic review. 29
Fabry's disease: a comparison of the effectiveness of two different enzyme replacement therapies 29
New insights for early assessment of cardiac involvement in Anderson-Fabry disease 29
La nefrotossicità dei farmaci immunosoppressori.Dalla ricerca alla clinica 28
Focal reduction in left ventricular 123I-metaiodobenzylguanidine uptake and impairment in systolic function in patients with Anderson-Fabry disease 28
Prevalence of GLA gene mutations and polymorphisms in patients with multiple sclerosis: A cross-sectional study 28
A clinical case of a giant lymphocele (LC) in a patient with a recent renal transplant is described] G Ital Nefrol 27
Does left ventricular function predict cardiac outcome in Anderson-Fabry disease? 27
Experimental evidence and clinical implications of Warburg effect in the skeletal muscle of Fabry disease 27
First experience of simultaneous PET/MRI for the early detection of cardiac involvement in patients with Anderson-Fabry disease 26
Acute kidney injury by radiographic contrast media: pathogenesis and prevention. 26
An unusual case of tuberous sclerosis incidentally discovered in adulthood: case report and review of the literature 26
Reduced intracranial volume in Fabry Disease: Evidence of abnormal neurodevelopment? 26
Author response: Alterations of functional connectivity of the motor cortex in Fabry disease: An RS-fMRI study 26
The effects of somatostatin analogues on liver volume and quality of life in polycystic liver disease: a meta-analysis of randomized controlled trials 26
Metabolic effects of two low protein diets in chronic kidney disease stage 4-5--a randomized controlled trial. 25
A classical phenotype of Anderson-Fabry disease in a female patient with intronic mutations of the GLA gene: a case report. 25
Renal denervation in ADPKD: an exceptional case 25
Multimodality imaging approach to Fabry cardiomyopathy: Any role for nuclear cardiology? 25
Early Biomarkers of Fabry Nephropathy: A Review of the Literature. 25
Effect of a low- versus moderate-protein diet on progression of CKD: follow-up of a randomized controlled trial. 24
Totale 4.054
Salva come PNG Salva come JPEG
Categoria #
all - tutte 23.169
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.169
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201940 0 0 0 0 0 0 0 0 0 6 8 26
2019/2020735 252 17 28 34 26 14 6 24 65 68 100 101
2020/2021672 15 23 46 27 64 73 33 32 80 28 85 166
2021/20221.185 20 4 11 13 15 37 37 52 113 109 261 513
2022/20231.352 224 125 50 119 144 147 19 126 221 81 74 22
2023/2024862 56 277 108 62 69 112 24 103 27 24 0 0
Totale 5.837